Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Change in obsessive beliefs as predictor and mediator of symptom change during treatment of obsessive-compulsive disorder – a process-outcome study

  • Alice Diedrich1Email author,
  • Philipp Sckopke2,
  • Caroline Schwartz1,
  • Sandra Schlegl1,
  • Bernhard Osen3,
  • Christian Stierle3 and
  • Ulrich Voderholzer4, 5
BMC PsychiatryBMC series – open, inclusive and trusted201616:220

https://doi.org/10.1186/s12888-016-0914-6

Received: 17 September 2015

Accepted: 8 June 2016

Published: 7 July 2016

Abstract

Background

Cognitive models of obsessive-compulsive disorder suggest that changes in obsessive beliefs are a key mechanism of treatments for obsessive-compulsive disorder. Thus, in the present process-outcome study, we tested whether changes in obsessive beliefs during a primarily cognitive behavioral inpatient treatment predicted treatment outcome and whether these changes mediated symptom changes over the course of treatment.

Methods

Seventy-one consecutively admitted inpatients with obsessive-compulsive disorder were assessed with the Yale-Brown Obsessive-Compulsive Scale and the Obsessive Beliefs Questionnaire at treatment intake, after six weeks of treatment and at discharge, and with the Beck-Depression-Inventory-II at intake and discharge.

Results

Changes in obsessive beliefs during the first six weeks of treatment predicted obsessive-compulsive symptoms at discharge when controlling for obsessive-compulsive and depressive symptoms at intake in a hierarchical regression analysis. Multilevel mediation analyses showed that reductions in obsessive beliefs partially mediated improvements in obsessive-compulsive symptoms over time.

Conclusions

Our findings indicate that decreasing obsessive beliefs in inpatient cognitive behavioral therapy for obsessive-compulsive disorder might be a promising treatment approach.

Keywords

Obsessive-compulsive disorder Inpatient treatment Cognitive behavioral therapy Obsessive beliefs Mediator Change mechanism

Background

Obsessive-compulsive disorder (OCD) is characterized by a pattern of repetitive obsessive thoughts, images, or impulses and a ritualized pattern of covert mental acts or overt behaviors, aimed at reducing associated negative emotions, including anxiety and fear [1]. According to the International Classification of Diseases-10 (ICD-10), three OCD subtypes exist: one with predominantly obsessional thoughts and ruminations, one with predominantly compulsive acts, and one with mixed obsessional thoughts and acts. OCD is a significant, often chronic [2, 3] and highly comorbid [4] mental health problem. Moreover, it is associated with a reduced quality of life [5], functional impairment [5], and anguish for patients and their families [6]. As such, it constitutes the 10th leading cause of disability among health conditions [7].

Cognitive behavioral therapy (CBT) including exposure and response prevention (ERP) as well as the modification of dysfunctional beliefs about the meaning and significance of obsessive thoughts has been recommended as the treatment of choice in treatment guidelines [810] – either alone or in combination with selective serotonin reuptake inhibitors. Several treatment outcome studies have established the (long-term) effectiveness of (C)BT and selective serotonin reuptake inhibitors in both out- and inpatient settings [1118]. However, prior research also shows that OCD symptoms persist at moderate levels even after an adequate treatment course [3, 11], and some studies indicate that about 30 to 50 % of patients do not benefit from CBT in terms of symptom reduction [11, 19, 20]. Thus, current treatments still need to be further improved. One way to reach this goal is to identify central predictors and mediators of symptom reductions during treatment for OCD [21, 22].

Cognitive behavioral models of OCD emphasize the role of dysfunctional beliefs in the development and maintenance of OCD (see for example, [2325]). Specifically, they postulate that obsessive beliefs contribute to negative appraisals of intrusive thoughts, i.e. obsessional thoughts, which may then cause compulsive behavior to reduce associated negative emotions. Hence, obsessive beliefs can be considered as predisposing factors of obsessional thoughts and compulsive acts. A number of cognitive models of OCD exist and each of those models focuses on a different belief domain regarding the etiology and maintenance of the disorder [23, 24, 26]. Consistently, the Obsessive Compulsive Cognitions Working Group (OCCWG) [27, 28] identified the following dysfunctional belief domains to be important in this context: inflated sense of personal responsibility, need for certainty, perfectionism, threat estimation, importance of thoughts, and need to control thoughts. Preliminary evidence for the significance of dysfunctional beliefs as a risk and maintaining factor in OCD comes from studies demonstrating positive cross-sectional associations between obsessive beliefs and obsessive-compulsive symptom severity both in non-clinical samples [29, 30] and samples with individuals suffering from OCD [3134].

Based on this theoretical and empirical background, it might be assumed that the extent of obsessive beliefs at the beginning of treatment impacts treatment outcome. Moreover, it might be hypothesized that changes over the course of treatment predict treatment outcome or even constitute an important mechanism of treatment in OCD. Preliminary evidence for these hypotheses comes from treatment studies indicating that symptom changes during psychotherapy and/or medical treatment are either predicted by the extent of obsessive beliefs at the beginning of treatment [35, 36] or associated with changes in obsessive beliefs during treatment [14, 35, 3740]. Only one study so far has yielded evidence that changes in maladaptive beliefs precede changes in obsessive-compulsive symptoms during an outpatient cognitive therapy [41]. However, until now, it has never been examined whether treatment-associated changes in obsessive beliefs predict and explain changes in obsessive-compulsive symptoms during an intensive primarily cognitive behavioral inpatient treatment. Therefore, the first aim of the present study was to examine whether changes in obsessive beliefs during the first six weeks of treatment predict treatment outcome in patients suffering from severe OCD. The second aim was to examine the mediating effect of changes in obsessive beliefs on symptom changes during treatment to test whether changes in obsessive beliefs cause changes in treatment outcome.

Methods

Participants and design

The present study was part of another study examining common factors of inpatient psychotherapy of patients suffering from OCD in an uncontrolled repeated measures design (in preparation). One hundred fifty six patients who received an inpatient treatment during January 2011 and May 2013 in two medical centers in Germany were included in the study. To be included, the participants were required to meet the criteria of an obsessive-compulsive disorder according to the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), to be fluent in German, and to be between 18 and 65 years of age. Participants were excluded if they had a high risk of suicide, an organic brain disorder, or a severe medical condition. To enhance the external validity of the study, we included patients who met criteria for comorbid disorders in addition to OCD, with the exception of patients with a current diagnosis of substance abuse or dependence, psychotic disorder or bipolar disorder. From the initial sample of 156 individuals, 42 participants were not included in the analyses as they were study or treatment drop-outs with missing data. Another 43 patients were excluded due to missing data without having dropped out from study or treatment. Thus, our final sample consisted of N = 71 individuals (for patient flow, see Fig. 1; for characteristics of the final sample, see Table 1).
Fig. 1

Flow chart of the sample. The described percentages refer to the sample size reported before

Table 1

Sample characteristics

 

M (SD)/% (N)

 

% (N)

Female gender

59.2 (42)

Comorbid mental disorders

83.1 (59)

Age (years)

34.59 (11.20)

Depressive disorders

77.5 (55)

High school degree

56.3 (40)

Dysthymic disorder

2.8 (2)

In a relationship

38.0 (27)

Anxiety disorders

18.3 (13)

OCD subtypes

 

Adjustment disorder

2.8 (2)

   F42.0

4.2 (3)

Somatoform disorders

4.2 (3)

   F42.1

5.6 (4)

Eating disorders

8.5 (6)

   F42.2

90.1 (64)

Personality disorders

9.9 (7)

Note. N = 71. OCD = Obsessive-Compulsive Disorder. F42.0 = Predominantly obsessional thoughts and ruminations, F42.1 = Predominantly compulsive acts, F42.2 = Mixed obsessional thoughts and acts. Anxiety disorders comprise panic disorder, generalized anxiety disorder, phobic disorder and posttraumatic stress disorder. As all participants were Caucasians we do not report differences with regard to ethnicity. High School = German equivalent of high school certificate after 13 years of schooling

Patients from the initial and the final sample did not differ significantly in terms of demographic (gender, age, education), clinical (type OCD, comorbidities, severity of obsessive-compulsive and depressive symptoms, extent of obsessive beliefs) or treatment-specific (duration, anti-depressive medication) variables (all ps > .05) except for relationship (χ 2 (1) = 4.32, p = .04). Individuals who were excluded from the study were more likely to be in a relationship than those who were included in the final sample.

Procedures

At admission to the hospital, an overall diagnostic assessment according to the criteria of ICD-10 was administered by clinical psychologists or psychiatrists for treatment purposes. For research purposes, DSM-IV diagnoses of OCD were also entered using the German version of the Structural Clinical Interview for DSM-IV [42]. It was conducted by clinical psychologists who had at least a Master’s degree and were enrolled in a PhD-program. The diagnostic assessments were thoroughly discussed with an experienced supervisor (as they were therapists in clinical training). Patients were assessed with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) [43] and the Obsessive Beliefs Questionnaire (OBQ) [44] at intake, after six weeks of treatment and at discharge, and with the Beck Depression Inventory-II (BDI-II) [45] at treatment intake and discharge. Means and standard deviations of the measures are provided in Table 2.
Table 2

Descriptive statistics for measurements at T1, T2, and T3

 

T1

T2

T3

 

M

SD

M

SD

M

SD

Y-BOCS

24.82

5.96

19.82

7.37

16.99

7.50

OBQ - Global

4.41

1.17

4.15

1.17

3.80

1.12

   OBQ-RES

4.78

1.69

4.55

1.61

4.25

1.59

   OBQ-PER

4.87

1.34

4.66

1.30

4.24

1.20

   OBQ-IMP

3.37

1.62

3.04

1.54

2.60

1.26

BDI-II

21.76

10.47

  

14.35

11.47

Note. N = 71. T1 = intake, T2 = after six weeks of treatment, T3 = discharge. Y-BOCS =  Yale-Brown Obsessive Compulsive Scale. OBQ - Global =  Obsessive Beliefs Questionnaire Global Score. RES =  responsibility and threat estimation. PER = perfectionism and intolerance for uncertainty. IMP =  importance and control of thoughts (metacognitions). BDI-II =  Beck Depression Inventory-II

Treatment

Patients received a multimodal, intensive inpatient treatment program including both individual and group psychotherapy. Individual therapy took place once or twice a week for 50 min. Group therapies included occupational therapy, music therapy, sports therapy, and a disorder-specific group. Individual therapy and the disorder-specific group were both based on the cognitive behavioral model. They included the following elements: psycho-education about OCD symptoms and the CBT rationale, individualized case formulation (including the identification of potential functions of the symptoms), in vivo ERP and the modification of interpretations of obsessive thoughts as well as of obsessive beliefs. However, the focus of the treatment lay on ERP - both therapist-guided and alone. Treatments were applied by clinical psychologists and/or psychiatrists who were all trained in CBT and supervised by experienced therapists. Most patients (84.5 %) took antidepressants during treatment. Mean treatment duration was 65.41 days (SD = 24.15). Almost all patients of the final sample (97.2 %) were discharged regularly.

Measures

Yale-Brown Obsessive Compulsive Scale

The German version of the Y-BOCS [43, 46] was used to measure the severity of OCD symptoms. In the present study, we utilized the clinician-administered semi-structured interview of the Y-BOCS at admission and discharge, and the self-report version after six weeks of treatment. Both versions were found to be interchangeable in a German sample [47]. The Y-BOCS is a 10-item-measure with five items designed to assess obsessional thoughts and five to assess compulsive behavior. Items are to be rated on a 5-point-scale ranging from 0 (no symptoms) to 4 (extreme symptoms). The German version of the Y-BOCS has shown good to very good inter-rater reliabilities, good internal consistency [48], and good convergent validity when compared to the Obsessive-Compulsive Inventory-Revised [49]. In the present study, the Y-BOCS displays good to excellent internal consistencies at all three assessment points (Cronbach’s α = .79 - .93).

Beck Depression Inventory-II

The BDI-II [45] is a widely used self-report questionnaire to measure depressive symptomatology within the last two weeks. The questionnaire consists of 21 items. For every item, participants have to choose one statement with an assigned value between 0 and 3. We used the German translation which exhibits satisfactory internal consistency, acceptable test-retest reliability, good convergent, discriminant and factorial validity, as well as good sensitivity to change [5052]. Consistent with the findings by Hautzinger and colleagues [50], the internal consistencies in the present study varied from good to excellent at treatment intake and discharge (Cronbach’s α = .88 - .93).

Obsessive Beliefs Questionnaire

The OBQ [44] is a 44-item questionnaire designed to measure the key belief domains of OCD identified by the OCCWG. It consists of three factor-analytically derived subscales: (1) responsibility and threat estimation; (2) perfectionism and intolerance for uncertainty; (3) importance and control of thoughts (metacognitions). Answers are rated on a 7-point-scale (1 = “disagree very much” to 7 = “agree very much”) [44]. In the present study, we used the abbreviated German adaptation of the OBQ [53]. Factor analyses of the translated English version resulted in one version with only twenty-four items loading on the same factors as the English version. All scales of the German version of the OBQ exhibit good internal consistencies, acceptable retest reliabilities, and satisfactory convergent and discriminant construct validity as well as criterion validity [53]. As such, the psychometric quality of the German adaptation of the OBQ is comparable to the English original [53]. Consistent with the findings by Ertle and colleagues [53], the internal consistencies of the OBQ found in the present study varied from good to excellent at the three assessment points (Cronbach’s α = .92 - .93).

Data analyses

To evaluate whether changes in obsessive beliefs during the first six weeks of treatment predict symptoms at discharge we conducted a hierarchical regression analysis. We entered obsessive-compulsive symptoms at intake of treatment in the first step and depressive symptoms at admission in the second step to control for potential confounding effects. Changes in obsessive beliefs between intake and six weeks of treatment were entered in the third step. To identify which specific obsessive belief domain best predicts treatment outcome, we conducted another hierarchical regression analysis. In this one, we also controlled for obsessive-compulsive and depressive symptom severity at intake (step 1 and 2) but entered changes in the three domains of the OBQ as predictors instead of the global score (step 3). We used SPSS version 23 for these analyses.

To examine whether changes in obsessive beliefs mediate changes in obsessive-compulsive symptoms, we used the procedure originally proposed by Baron and Kenny [54] and applied it to a multilevel framework as recently suggested [55]. For these analyses, we used the software R [56] with packages lme4 [57] and lmerTest [58]. The longitudinal nature of our design produced a multilevel data structure [55, 59], in which the lower level, or Level 1 data (i.e. the repeated measures of both obsessive-compulsive symptoms and obsessive beliefs), were nested within upper level, or Level 2, units (i.e. the participants). This data structure is appropriate for contemporary growth curve modeling techniques [60]. Given that pre-scores varied between the individuals, we examined this change over time in a multilevel random coefficient regression framework [61, 62]. According to the approach by Kenny, Korchmaros, & Bolger [63], mediation can be established if the following four statistical criteria are met: (1) Predictor and mediator are significantly related (path a), (2) predictor and criterion are significantly correlated (path c), (3) mediator and criterion are significantly related when the predictor is controlled for (path b), and (4) the relationship between predictor and criterion is smaller when the mediator is controlled for (path c’) compared to when it is not (path c). To examine whether obsessive beliefs mediate symptom changes, we tested a lower level mediation model [63], in which time (intake, after six weeks of treatment, discharge) was the predictor variable, obsessive-compulsive symptom severity the criterion, and obsessive beliefs the mediator. To control for potential confounding effects of changes in depressive symptom severity during treatment, we included changes in depressive symptoms during treatment as another predictor in each of the three regression analyses. The decision to control for (changes in) depressive symptom severity in our analyses was based on the high rate of depressive disorders in the sample of the present study. Moreover, it was based on prior research indicating confounding effects of (changes in) depressive symptoms both on treatment outcome [37, 64] as well as on the relation between changes in obsessive beliefs and obsessive-compulsive symptoms post-treatment [65]. Further potentially confounding variables such as gender, age, treatment duration, anti-depressive medication and comorbidities were neither related to (changes in) obsessive-compulsive symptoms nor to changes in obsessive beliefs (all ps > .05). Thus, we did not enter them as further covariates in our analyses. However, as individual means of the mediator may alter the estimation of paths in a multilevel framework [66], we included values of the mediator that were centered on the individual mean (group-mean centering) as well. We used Sobel’s test [67] to test the significance of the indirect effect of the hypothesized mediation model (i.e., the product of the regression weights from paths a and b). The test has already been discussed in a multilevel framework by Krull and MacKinnon [68]. For all our analyses, we set alpha at p < .05.

Results

Regression analyses

Results of the first hierarchical regression analysis are presented in Table 3. They indicate that - when controlling for obsessive compulsive symptom severity (β = .49, t = 4.77, p < .001) and depressive symptom load (β = .07, t = 0.73, p = .47) at intake - changes of obsessive beliefs (global score) between intake and after six weeks of treatment significantly predicted obsessive-compulsive symptoms at discharge (β = -.24, t = -2.38, p = .02) and explained 6 % of the outcome variance (ΔF(1,67) = 5.64, p = .02).
Table 3

Regression analysis with obsessive-compulsive symptoms (T3) as outcome and obsessive belief-changes (∆T1-T2) as predictor

 

R 2

F

p

B

SE B

β

t

p

Step 1

.27

26.03

< .001

     

   Y-BOCS T1

   

0.66

0.13

.52

5.10

< .001

Step 2

.01

0.71

.40

     

   Y-BOCS T1

   

0.63

0.13

.50

4.77

< .001

   BDI-II T1

   

0.06

0.08

.09

0.85

.40

Step 3

.06

5.64

.02

     

   Y-BOCS T1

   

0.61

0.13

.49

4.77

< .001

   BDI-II T1

   

0.05

0.07

.07

0.73

.47

   OBQ-Global ∆T1-T2

   

-1.89

0.80

-.24

-2.38

.02

Note. N = 71. Obsessive-compulsive and depressive symptoms (T1) were entered as covariates. T1 = intake, T2 = after six weeks of treatment, T3 = discharge. Y-BOCS = Yale-Brown Obsessive Compulsive Scale. OBQ-Global = Obsessive Beliefs Questionnaire Global Score. BDI-II = Beck Depression Inventory-II

As indicated in Table 4, the second hierarchical regression analysis showed that after controlling for variance explained by obsessive-compulsive and depressive symptom load at intake, entering all three belief domains in the next regression step revealed a clear tendency towards significance for the prediction of obsessive-compulsive symptoms at discharge (∆F(3,65) = 2.68, p = .05). All three belief domains together accounted for 8 % of the variance of outcome. Findings also indicated a trend for the domain “importance and control of thoughts” to independently predict treatment outcome (β = -.20, t = -1.74, p = .09).
Table 4

Multiple regression with obsessive-compulsive symptoms (T3) as outcome and belief domain-changes (∆T1-T2) as predictors

 

R

F

p

B

SE B

β

t

p

Step 1

.27

26.03

< .001

     

   Y-BOCS T1

   

0.66

0.13

.52

5.10

< .001

Step 2

.01

0.71

.40

     

   Y-BOCS T1

   

0.63

0.13

.50

4.77

< .001

   BDI-II T1

   

0.06

0.08

.09

0.85

.40

Step 3

.08

2.68

.05

     

   Y-BOCS T1

   

0.60

0.13

.48

4.46

< .001

   BDI-II T1

   

0.08

0.08

.11

1.03

.31

   OBQ-RES ∆T1-T2

   

0.34

0.68

.06

0.50

.62

   OBQ-PER ∆T1-T2

   

-1.18

0.86

-.17

-1.37

.18

   OBQ-IMP ∆T1-T2

   

-1.16

0.67

-.20

-1.74

.09

Note. N = 71. Obsessive-compulsive and depressive symptoms (T1) were entered as covariates. T1 = intake, T2 = after six weeks of treatment, T3 = discharge. Y-BOCS = Yale-Brown Obsessive Compulsive Scale. OBQ = Obsessive Beliefs Questionnaire. RES = responsibility and threat estimation. PER = perfectionism and intolerance for uncertainty. IMP = importance and control of thoughts (metacognitions). BDI-II = Beck Depression Inventory-II

Mediation analyses

Table 5 and Fig. 2 both show the results of the mediation analyses. When time was entered into the Level 1 regression equation predicting obsessive-compulsive symptom severity (path c) while controlling for changes in depressive symptom load between treatment intake and discharge, the regression coefficient indicated that obsessive-compulsive symptoms decreased significantly over the course of treatment (B = -3.92, p < .001). When time was entered into the Level 1 regression equation predicting obsessive beliefs (path a) while controlling for depressive symptom change, the regression coefficient showed that obsessive beliefs decreased significantly over time as well (B = -0.32, p < .001). When both time and depressive symptom change were controlled for, the regression coefficient showed that obsessive beliefs significantly predicted obsessive-compulsive symptoms (path b; B = 1.77, p = .001). This indicates that participants who showed fewer obsessive beliefs also suffered from a lower degree of obsessive-compulsive symptoms. Finally, when controlling for both obsessive beliefs and depressive symptom change, time still significantly predicted obsessive-compulsive symptoms (path c‘; B = -3.35, p < .001), but the regression coefficient was smaller than the one of path c. This is an indicator of a partial mediation. Sobel’s test of the indirect effect of time on obsessive-compulsive symptoms via obsessive beliefs was significant (ab = -0.57, z = -3.03, p = .002). Thus, all criteria for a partial mediation are met. This indicates that changes in obsessive-compulsive symptoms may be explained by changes in obsessive beliefs during inpatient treatment.
Table 5

Regression analyses for the hypothesized mediation model with obsessive beliefs as mediator

Step

Path

Predictor variable

Outcome variable

B

SE B

t

p

1

c

Time

Y-BOCS

-3.92

0.38

-10.41

< .001

2

a

Time

OBQ - Global

-0.32

0.05

-6.94

< .001

3

b

OBQ - Global

Y-BOCS

1.77

0.54

3.27

.001

 

c'

Time

Y-BOCS

-3.35

0.40

-8.29

< .001

Note. N = 71. Y-BOCS = Yale-Brown Obsessive Compulsive Scale. OBQ - Global = Obsessive Beliefs Questionnaire Global Score

Fig. 2

Mediation model with obsessive beliefs as mediator between time of measurement and obsessive-compulsive symptoms. N = 71. The unstandardized regression coefficients are presented. *p < .05, **p < .01, ***p < .001

To examine whether treatment-associated changes in obsessive beliefs result both in changes in obsessions and compulsions, we computed two exploratory post-hoc mediational models: one with obsession severity as criterion and another one with compulsion severity as criterion while controlling for depressive symptom changes. Results show that changes in obsessive beliefs partially mediate the association between time and obsessions (b: B = 1.08, p < .001; c: B = -1.85, p < .001; c’: B = -1.51, p < .001; ab = -0.35, z = -3.19, p = .001), and between time and compulsions (b: B = 0.86, p = .008; c: B = -1.94, p < .001; c’: B = -1.66, p < .001; ab = -0.28, z = -2.55, p = .01). A comparison of the regression coefficients of the indirect effect of both models indicates that changes in obsessive beliefs explain changes in obsessions and compulsions to a similar extent. However, these findings should not be over-interpreted due to multiple testing and a potential alpha-error-accumulation.

Discussion

The present study showed that changes in global obsessive beliefs during the first part of an intensive, primarily cognitive behavioral inpatient treatment for individuals with severe OCD predict treatment outcome. Further on, it offered preliminary evidence that changes in beliefs regarding the importance of thoughts and the need to control thoughts are most important in predicting treatment outcome when considering the belief domains identified by the OCCWG [27, 28]. Finally, it pointed out that changes in obsessive beliefs partially explain patients’ improvements during treatment and may thus constitute an essential change mechanism in intensive cognitive behavioral inpatient treatment for OCD.

Our findings are consistent with the large body of evidence demonstrating positive cross-sectional associations between obsessive beliefs and obsessive-compulsive symptom severity [3134]. Moreover, they add to the findings that symptom changes during cognitive, behavioral and cognitive behavioral treatments are either predicted by the extent of obsessive beliefs at the beginning of treatment [35, 36] or even associated with [14, 35, 3739] or predicted by [41] changes in obsessive beliefs during treatment. The finding that changes in obsessive beliefs partially mediated symptom changes is consistent with results showing that emotion activation and habituation explain symptom changes during CBT as well [6971]. The non-significant trend of changes in metacognitions as a predictor of outcome is consistent with previous research showing that changes in metacognitions is the only obsessive belief domain that is associated with symptom changes during (C)BT [35, 41, 65]. Finally, our findings extend previous research as they show that changes in obsessive beliefs during an intensive inpatient CBT predict symptom changes longitudinally and even explain treatment success.

Thus, from a theoretical perspective, our results add weight to cognitive and meta-cognitive models of OCD that emphasize the role of dysfunctional (meta-cognitive) beliefs in the development and maintenance of OCD (see for example, [2326]) and suggest that reductions in (metacognitive) obsessive beliefs lead to reductions in obsessive symptom severity. From a clinical perspective, they indicate that changes in obsessive beliefs are one of the working mechanisms of inpatient CBT in OCD. Thus, focusing more strongly on changing obsessive beliefs in CBT for OCD seems to be a promising treatment approach, especially as the extent of changes in obsessive beliefs in the present study was rather small; with a greater focus on obsessive beliefs, even greater symptom changes might be achieved.

Unfortunately, prior research does not unambiguously show which treatment is best suited to foster changes in obsessive beliefs. While it is clear that both CBT and ERP and cognitive therapy alone have the potential to decrease obsessive beliefs [14, 37, 7274], findings regarding a potential superiority of either ERP or CT in changing dysfunctional beliefs are inconclusive. Whereas two studies show that ERP is sufficient to produce strong improvements in both obsessive-compulsive behavior and cognitions [36, 72], another study indicates that ERP is more effective if it is configured as a behavioral experiment rather than when it is accompanied by a habituation rationale [75]. Thus, at this point in time, it seems to be best practice to combine behavioral and cognitive elements in inpatient treatment for OCD (to enhance changes in obsessive beliefs) as recommended by current practice guidelines [810]. However, findings from the present study suggest focusing on potential changes in (metacognitive) obsessive beliefs in ERP debriefing to use the advantages of both behavioral and cognitive interventions.

Strengths of the present study consist in including a comparatively large number of inpatients with a validated diagnosis of OCD and in assessing obsessive-compulsive symptoms as well as obsessive beliefs at multiple assessment points. Limitations of the present study include the inpatient setting of the study and the lack of subgroup analyses for several OCD subtypes due to the limited sample size. The evaluation of a multimodal inpatient treatment concept without a waiting control group neither allows us to unambiguously conclude that symptom changes over time are due to treatment at all nor due to a specific treatment element. More specifically, our study does not provide any information about the exact effect of each treatment element on changes both in obsessive beliefs and obsessive-compulsive symptoms. Given that treatment consisted of both a disorder-specific individual and group therapy, and of a variety of additional therapies (occupational therapy, music therapy, sports therapy), we cannot specify which element is (most) responsible for changes in obsessive beliefs and obsessive-compulsive symptoms. Finally, our sample size precluded us from conducting analyses in OCD subgroups. This is unfortunate as specific dimensions of obsessive beliefs seem to be associated with specific types of OCD (e.g., elevated responsibility and threat estimation in the washing-/checking-subtype, elevated importance and control of thoughts in the checking-subtype, elevated perfectionism and uncertainty in the symmetry and ordering subtype; [3134]). It might be that dimensions of obsessive beliefs that change during treatment (for example metacognitions) depend on the subtype of OCD the patients suffer from.

Future research should address these questions in controlled studies with larger sample sizes as these findings could have important implications for understanding variability in treatment response [76] and thus for improving treatment outcome. Given the multimodal treatment concept of the present study, future studies should assess and examine the specific contribution of stand-alone treatment elements in inpatient treatments on changes in obsessive beliefs and obsessive-compulsive symptoms. Moreover, future research should focus on investigating specific change mechanisms (i.e. habituation and changes in obsessive beliefs) in ERP and cognitive therapy in inpatient settings so that mediating effects can unambiguously be attributed to a specific treatment. Finally, future research should test whether (meta-)cognitive therapy enhances treatment outcome and thus is indicated in specific individuals and situations, for example in non-responders to behavioral therapy [77], in patients who primarily suffer from obsessive thoughts [78] or from strong belief distortions [79], and/or in patients with a strong aversion to exposure therapy [79].

Conclusions

Changes in obsessive beliefs are one of the working mechanisms of multimodal, but primarily cognitive behavioral inpatient treatment in OCD. Thus, focusing more strongly on changing obsessive beliefs in (inpatient) CBT for OCD seems to be a promising treatment approach that might help further improve current treatments for individuals with OCD. Finally, it might represent an alternative treatment approach for non-responder to behavioral interventions and for those who suffer from strong cognitive biases or who reject exposure-based interventions.

Abbreviations

BDI-II, beck depression inventory-II; CBT, cognitive behavioral therapy; DSM-IV, diagnostic and statistical manual of mental disorders-IV; ERP, exposure and response prevention; ICD-10, international classification of diseases-10; IMP, importance and control of thoughts (metacognitions); OBQ, obsessive beliefs questionnaire; OCCWG, obsessive compulsive cognitions working group; OCD, obsessive-compulsive disorder; PER, perfectionism and intolerance for uncertainty; RES, responsibility and threat estimation; Y-BOCS, yale-brown obsessive-compulsive scale

Declarations

Acknowledgements

We wish to thank Christiane Schubert and Barbara Kaier for their involvement in the collection of study data.

Funding

This study was funded by the Schön Clinic and the University of Munich (LMU).

Availability of data and materials

The dataset supporting the conclusions of this article is available in the open science framework repository (https://osf.io/c7f58/).

Authors’ contributions

AD drafted the manuscript. AD and PS performed the statistical analyses. AD, CS, SS and PS have made substantial contributions to the interpretation of data. CS, SS and CS participated in the coordination of the study and contributed to data acquisition. CS, BO and UV conceived of the study and participated in its design. All authors revised the manuscript and approved the final version.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Written informed consent was obtained from all participants prior to the assessments, and ethical approval for the study was granted by the ethics committee of the University of Munich (LMU), Pettenkoferstr. 8a, 80336 Munich, Germany.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Psychiatry and Psychotherapy, University of Munich (LMU)
(2)
Department of Psychology, University of Munich (LMU)
(3)
Schön Clinic Bad Bramstedt
(4)
Schön Clinic Roseneck
(5)
Department of Psychiatry and Psychotherapy, University of Freiburg

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.View ArticleGoogle Scholar
  2. Ayuso-Mateos JL. Global burden of obsessive-compulsive disorder in the year 2000. Geneva, Switzerland: World Health Organization; 2000.Google Scholar
  3. Eisen JL, Pinto A, Mancebo MC, Dyck IR, Orlando ME, Rasmussen SA. A 2-year prospective follow-up study of the course of obsessive-compulsive disorder. J Clin Psychiat. 2010;71:1033–9.View ArticleGoogle Scholar
  4. Hofmeijer-Sevink MK, Van Oppen P, Van Megen HJ, Batelaan NM, Cath DC, Van Der Wee NJA, et al. Clinical relevance of comorbidity in obsessive compulsive disorder: The Netherlands OCD Association study. J Affect Disord. 2013;150:847–54.View ArticlePubMedGoogle Scholar
  5. Huppert JD, Simpson HB, Nissenson KJ, Liebowitz MR, Foa EB. Quality of life and functional impairment in obsessive-compulsive disorder: A comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depress Anxiety. 2009;26:39–45.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Torres AR, Hoff NT, Padovani CR, Ramos-Cerqueira ATDA. Dimensional analysis of burden in family caregivers of patients with obsessive-compulsive disorder. Psychiat Clin Neuros. 2012;66:432–41.View ArticleGoogle Scholar
  7. Murray CJL, Lopez A. The Global Burden of Disease, volume 1: A comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press; 1996.Google Scholar
  8. American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Arlington: American Psychiatric Association; 2007.Google Scholar
  9. Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde. S3-Leitlinie Zwangsstörungen. 2013. http://www.dgppn.de/fileadmin/user_upload/_medien/download/pdf/kurzversion-leitlinien/S3-Leitlinie_Zwangsstörungen_lang.pdf. Accessed 09 Sept 2015.
  10. National Institute for Health and Clinical Excellence. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. Leicester: British Psychological Society; 2006.Google Scholar
  11. Eddy KT, Dutra L, Bradley R, Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clin Psychol Rev. 2004;24:1011–30.View ArticlePubMedGoogle Scholar
  12. Olatunji BO, Davis ML, Powers MB, Smits JAJ. Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013;47:33–41.View ArticlePubMedGoogle Scholar
  13. Romanelli RJ, Wu FM, Gamba R, Mojtabai R, Segal JB. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of head-to-head randomized controlled trials. Depress Anxiety. 2014;31:641–52.View ArticlePubMedGoogle Scholar
  14. Cottraux J, Note I, Yao SN, Lafont S, Note B, Mollard E, et al. A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychother Psychosom. 2001;70:288–97.View ArticlePubMedGoogle Scholar
  15. Koran LM, Hackett E, Rubin A, Wolkow R, Robinson D. Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder. Am J Psychiat. 2002;159:88–95.View ArticlePubMedGoogle Scholar
  16. Brennan BP, Lee C, Elias JA, Crosby JM, Mathes BM, Andre M-C, et al. Intensive residential treatment for severe obsessive-compulsive disorder: Characterizing treatment course and predictors of response. J Psychiat Res. 2014;56:98–105.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Gönner S, Limbacher K, Ecker W. Stationäre kognitive Verhaltenstherapie bei Zwangsstörungen: Effektivität und Erfolgsprädiktoren in der Routineversorgung. Verhaltenstherapie. 2012;22:17–26.View ArticleGoogle Scholar
  18. Kordon A, Kahl KG, Broocks A, Voderholzer U, Rasche-Räuchle H, Hohagen F. Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: Results from a two-year follow-up. Eur Arch Psy Clin N. 2005;255:48–50.View ArticleGoogle Scholar
  19. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiat. 2006;51:407–16.Google Scholar
  20. Simon M, Althaus D, Röper G, Butollo W, Hauke W, Zaudig M. Die stationäre Behandlung von Zwangsstörungen mit multimodaler Verhaltenstherapie. Eine 1-Jahres-Katamnese. Psychotherapeut. 2004;49:46–50.View ArticleGoogle Scholar
  21. Knopp J, Knowles S, Bee P, Lovell K, Bower P. A systematic review of predictors and moderators of response to psychological therapies in OCD: Do we have enough empirical evidence to target treatment? Clin Psychol Rev. 2013;33:1067–81.View ArticlePubMedGoogle Scholar
  22. Polman A, Bouman TK, van Hout WJPJ, de Jong PJ, den Boer JA. Processes of change in cognitive-behavioural treatment of obsessive-compulsive disorder: Current status and some future directions. Clin Psychol Psychot. 2010;17:1–12.Google Scholar
  23. Fisher PL, Wells A. Metacognitive therapy for obsessive–compulsive disorder: A case series. J Behav Ther Exp Psy. 2008;39:117–32.View ArticleGoogle Scholar
  24. Frost RO, Steketee G. Cognitive approaches to obsessions and compulsions: Theory, assessment, and treatment. Oxford: Elsevier; 2002.Google Scholar
  25. Rachman S. A cognitive theory of obsessions: Elaborations. Behav Res Ther. 1998;36:385–401.View ArticlePubMedGoogle Scholar
  26. Salkovskis PM. Cognitive-behavioural factors and the persistence of intrusive thoughts in obsessional problems. Behav Res Ther. 1989;27:677–82.View ArticlePubMedGoogle Scholar
  27. Obsessive Compulsive Cognitions Working Group. Cognitive assessment of obsessive-compulsive disorder. Behav Res Ther. 1997;35:667–81.View ArticleGoogle Scholar
  28. Obsessive Compulsive Cognitions Working Group. Development and initial validation of the obsessive beliefs questionnaire and the interpretation of intrusions inventory. Behav Res Ther. 2001;39:987–1006.View ArticleGoogle Scholar
  29. Abramowitz JS, Lackey GR, Wheaton MG. Obsessive-compulsive symptoms: The contribution of obsessional beliefs and experiential avoidance. J Anxiety Disord. 2009;23:160–6.View ArticlePubMedGoogle Scholar
  30. Fergus TA, Wu KD. Do symptoms of generalized anxiety and obsessive-compulsive disorder share cognitive processes? Cognitive Ther Res. 2010;34:168–76.View ArticleGoogle Scholar
  31. Brakoulias V, Starcevic V, Berle D, Milicevic D, Hannan A, Martin A. The relationships between obsessive-compulsive symptom dimensions and cognitions in obsessive-compulsive disorder. Psychiat Quart. 2014;85:133–42.View ArticlePubMedGoogle Scholar
  32. Calleo JS, Hart J, Björgvinsson T, Stanley MA. Obsessions and worry beliefs in an inpatient OCD population. J Anxiety Disord. 2010;24:903–8.View ArticlePubMedGoogle Scholar
  33. Smith AH, Wetterneck CT, Hart JM, Short MB, Björgvinsson T. Differences in obsessional beliefs and emotion appraisal in obsessive compulsive symptom presentation. J Obsessive Compuls Relat Disord. 2012;1:54–61.View ArticleGoogle Scholar
  34. Wheaton MG, Abramowitz JS, Berman NC, Riemann BC, Hale LR. The relationship between obsessive beliefs and symptom dimensions in obsessive-compulsive disorder. Behav Res Ther. 2010;48:949–54.View ArticlePubMedGoogle Scholar
  35. Adams TG, Riemann BC, Wetterneck CT, Cisler JM. Obsessive beliefs predict cognitive behavior therapy outcome for obsessive compulsive disorder. Cogn Behav Ther. 2012;41:203–11.View ArticlePubMedGoogle Scholar
  36. Selvi Y, Atli A, Besiroglu L, Aydin A, Gulec M. The impact of obsessive beliefs on pharmacological treatment response in patients with obsessive-compulsive disorder. Int J Psychiat Clin. 2011;15:209–13.View ArticleGoogle Scholar
  37. Whittal ML, Thordarson DS, McLean PD. Treatment of obsessive-compulsive disorder: Cognitive behavior therapy vs. exposure and response prevention. Behav Res Ther. 2005;43:1559–76.View ArticlePubMedGoogle Scholar
  38. Williams TI, Salkovskis PM, Forrester EA, Allsopp MA. No changes in symptoms of OCD and appraisal of responsibility during cognitive behavioural treatment: A pilot study. Behav Cogn Psychoth. 2002;30:69–78.Google Scholar
  39. Woody SR, Whittal ML, McLean PD. Mechanisms of symptom reduction in treatment for obsessions. J Consult Clin Psych. 2011;79:653–64.View ArticleGoogle Scholar
  40. Farrell L, Boschen M. Treatment outcome in adult OCD: Predictors and processes of change. Asia Pac J Couns Psychother. 2011;2:82–97.Google Scholar
  41. Wilhelm S, Berman NC, Keshaviah A, Schwartz RA, Steketee G. Mechanisms of change in cognitive therapy for obsessive compulsive disorder: Role of maladaptive beliefs and schemas. Behav Res Ther. 2015;65:5–10.View ArticlePubMedGoogle Scholar
  42. Wittchen H, Zaudig M, Fydrich T. Strukturiertes Klinisches Interview für DSM-IV. Göttingen: Hogrefe; 1997.Google Scholar
  43. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The yale-brown obsessive compulsive scale. II. Validity. Arch Gen Psychiat. 1989;46:1012–6.View ArticlePubMedGoogle Scholar
  44. Obsessive Compulsive Cognitions Working Group. Psychometric validation of the obsessive belief questionnaire and interpretation of intrusions inventory—Part 2: Factor analyses and testing of a brief version. Behav Res Ther. 2005;43:1527–42.View ArticleGoogle Scholar
  45. Beck AT, Steer RA, Brown GK. Beck Depression Inventory – Second Edition. Manual. San Antonio: The Psychological Corporation; 1996.Google Scholar
  46. Hand I, Büttner-Westphal H. Die yale-brown obsessive compulsive scale (Y-BOCS): Ein halbstrukturiertes Interview zur Beurteilung des Schweregrades von Denk- und Handlungszwängen. Verhaltenstherapie. 1991;1:223–5.View ArticleGoogle Scholar
  47. Schaible R, Armbrust M, Nutzinger DO. Yale-brown obsessive compulsive scale: sind selbst- und fremdrating äquivalent? Verhaltenstherapie. 2001;11:298–303.View ArticleGoogle Scholar
  48. Jacobsen D, Kloss M, Fricke S, Hand I, Moritz S. Reliabilität der Deutschen version der yale-brown obsessive compulsive scale. Verhaltenstherapie. 2003;13:111–3.View ArticleGoogle Scholar
  49. Gönner S, Ecker W, Leonhart R. Diagnostic discrimination of patients with different OCD main symptom domains from each other and from anxious and depressive controls. J Psychopathol Behav. 2009;31:159–67.View ArticleGoogle Scholar
  50. Hautzinger M, Keller F, Kühner C. BDI-II. Beck Depressions-Inventar (BDI-II). Revision. Frankfurt/Main: Harcourt Test Services; 2006.Google Scholar
  51. Keller F, Hautzinger M, Kühner C. Zur faktoriellen Struktur des Deutschsprachigen BDI-II. Z Kl Psych Psychoth. 2008;37:245–54.View ArticleGoogle Scholar
  52. Kühner C, Bürger C, Keller F, Hautzinger M. Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results from German samples. Nervenarzt. 2007;78:651–6.View ArticlePubMedGoogle Scholar
  53. Ertle A, Wahl K, Bohne A, Moritz S, Kordon A, Schulte D. Dimensionen zwangsspezifischer Einstellungen der Obsessive-Beliefs Questionnaire (OBQ) für den Deutschen Sprachraum analysiert. Z Klin Psych. 2008;37:263–71.View ArticleGoogle Scholar
  54. Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–82.View ArticlePubMedGoogle Scholar
  55. Kenny D, Kashy D, Bolger N. Data analysis in social psychology. In: Gilbert D, Fiske S, Lindzey G, editors. The Handbook of Social Psychology. Boston: McGraw-Hill; 1998. p. 233–65.Google Scholar
  56. R Development Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. 2008. https://www.r-project.org/. Accessed 10 Sept 2015.
  57. Bates D, Maechler M, Bolker B, Walker S, Christensen RHB, Singmann H, et al. Lme4: Linear mixed-effects models using Eigen and S4 (Version 1.1-7). 2014. http://cran.r-project.org/web/packages/lme4/index.html. Accessed 09 Sept 2015.
  58. Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest: Tests for random and fixed effects for linear mixed effect models (lmer objects of lme4 package) (Version 2.0-11). 2014. http://cran.us.r-project.org/web/packages/lmerTest/index.html. Accessed 10 Sept 2015.
  59. Raudenbush SW, Bryk AS. Hierarchical linear models: Applications and data analysis methods. Newbury Park: Sage; 2002.Google Scholar
  60. Collins LM, Sayer A. New methods for the analysis of change. Decade of behavior. Washington: American Psychological Association; 2001.View ArticleGoogle Scholar
  61. Raudenbush SW. Toward a Coherent Framework for Comparing Trajectories of Individual Change. In: Collins LM, Sayer AG, editors. New methods for the analysis of change. Washington, DC: American Psychiatric Association; 2001. p. 33–64.Google Scholar
  62. Raudenbush SW. Comparing personal trajectories and drawing causal inferences from longitudinal data. Annu Rev Psychol. 2001;52:501–25.View ArticlePubMedGoogle Scholar
  63. Kenny D, Korchmaros JD, Bolger N. Lower level mediation in multilevel models. Psychol Methods. 2003;8:115–28.View ArticlePubMedGoogle Scholar
  64. Abramowitz JS, Franklin ME, Street GP, Kozak MJ, Foa EB. Effects of comorbid depression on response to treatment for obsessive-compulsive disorder. Behav Ther. 2000;31:517–28.View ArticleGoogle Scholar
  65. Solem S, Håland ÅT, Vogel PA, Hansen B, Wells A. Change in metacognitions predicts outcome in obsessive-compulsive disorder patients undergoing treatment with exposure and response prevention. Behav Res Ther. 2009;47:301–7.View ArticlePubMedGoogle Scholar
  66. Zhang Z, Zyphur MJ, Preacher KJ. Testing multilevel mediation using hierarchical linear models problems and solutions. Organ Res Methods. 2009;12:695–719.View ArticleGoogle Scholar
  67. Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol. 1982;13:290–312.View ArticleGoogle Scholar
  68. Krull JL, MacKinnon DP. Multilevel mediation modeling in group-based intervention studies. Evaluation Rev. 1999;23:418–44.View ArticleGoogle Scholar
  69. Foa EB, Grayson JB, Steketee GS, Doppelt HG, Turner RM, Latimer PR. Success and failure in the behavioral treatment of obsessive-compulsives. J Consult Clin Psych. 1983;51:287–97.View ArticleGoogle Scholar
  70. Kirkby KC, Berrios GE, Daniels BA, Menzies RG, Clark A, Romano A. Process-outcome analysis in computer-aided treatment of obsessive- compulsive disorder. Compr Psychiat. 2000;41:259–65.View ArticlePubMedGoogle Scholar
  71. Kozak MJ, Foa EB, Steketee G. Process and outcome of exposure treatment with obsessive-compulsives: Psychophysiological indicators of emotional processing. Behav Ther. 1988;19:157–69.View ArticleGoogle Scholar
  72. Storchheim LF, O’Mahony JF. Compulsive behaviours and levels of belief in obsessive–compulsive disorder: a case‐series analysis of their interrelationships. Clin Psychol Psychother. 2006;13:64–79.View ArticleGoogle Scholar
  73. Whittal ML, Robichaud M, Thordarson DS, McLean PD. Group and individual treatment of obsessive-compulsive disorder using cognitive therapy and exposure plus response prevention: a 2-year follow-up of two randomized trials. J Consult clin Psych. 2008;76:1003–14.View ArticleGoogle Scholar
  74. Wilhelm S, Steketee G, Reilly-Harrington NA, Deckersbach T, Buhlmann U, Baer L. Effectiveness of Cognitive Therapy for Obsessive-Compulsive Disorder: An Open Trial. J Cogn Psychother. 2005;19:173–9.View ArticleGoogle Scholar
  75. Fisher PL, Wells A. Experimental modification of beliefs in obsessive-compulsive disorder: A test of the metacognitive model. Behav Res Ther. 2005;43:821–9.View ArticlePubMedGoogle Scholar
  76. Calamari JE, Wiegartz PS, Janeck AS. Obsessive-compulsive disorder subgroups: A symptom-based clustering approach. Behav Res Ther. 1999;37:113–25.View ArticlePubMedGoogle Scholar
  77. Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:400–12.View ArticlePubMedGoogle Scholar
  78. Andouz Z, Dolatshahi B, Moshtagh N, Dadkhah A. The efficacy of metacognitive therapy on patients suffering from pure obsession. Iran J Psychiatry. 2012;7:11–21.PubMedPubMed CentralGoogle Scholar
  79. McLean PD, Whittal ML, Thordarson DS, Taylor S, Söchting I, Koch WJ, et al. Cognitive versus behavior therapy in the group treatment of Obsessive-Compulsive disorder. J Consult Clin Psych. 2001;69:205–14.View ArticleGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement